You have access
A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer –ACTOR Study–
MITSUKUNI SUENAGA, TAKASHI AKIYOSHI, EIJI SHINOZAKI, YOSHIYA FUJIMOTO, SATOSHI MATSUSAKA, TSUYOSHI KONISHI, SATOSHI NAGAYAMA, YOSUKE FUKUNAGA, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, TAKAHITO SUGISAKI, MASASHI UENO and TOSHIHARU YAMAGUCHI
Anticancer Research March 2018, 38 (3) 1741-1747;